FDA Adverse Event Malfunction Summary report: N

COAGUCHEK XS SYSTEM

MDR report key: 1063748 · Received June 19, 2008

Report

Report Number
1823260-2008-04834
Event Type
Malfunction
Date Received
June 19, 2008
Date of Event
June 6, 2008
Report Date
June 19, 2008
Manufacturer
ROCHE DIAGNOSTICS
Product Code
GJS
PMA / PMN Number
K062925
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CO, US
Reporter Occupation
NURSE

Narratives

Description of Event or Problem · 1

CUSTOMER STATES THE PATIENT TESTED 4.4 INR ON THE COAGUCHEK XS SYSTEM AND 3.05 INR ON A COMPARISON LAB. NO ACTION TAKEN ON DEVICE RESULT. NO ADVERSE EVENT REPORTED. REQUESTED RETURN OF SUSPECT SYSTEM AND REPLACEMENT WAS SENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COAGUCHEK XS SYSTEM PROTHROMBIN TIME TEST STRIPS - GJS GJS ROCHE DIAGNOSTICS 20162831

Patients

Seq Age Sex Outcome Treatment
1 41 YR CELEBREX - 200MG/DAY| COUMADIN - .5MG/DAY| VALIUM - 5MG/AS NEEDED| TAMOXIFEN CITRATE - 20MG/DAY| SENNA - 50MG/AS NEEDED| MIRALAX - 34G/DAY| DILAUDID - 2MG/AS NEEDED| ANCEF - 2G/8 HOURS| VITAMIN C| ABILIFY - 2MG/DAY| CALCIUM + D| FENTORA - 100MCG/AS NEEDED| FENTANYL LOLLIPOP - 200MCG/AS NEEDED| FENTANYL PATCH - 20MCG/DAY| ZOFRAN - 4MG/AS NEEDED| LORAZEPAM - 1MG/AS NEEDED| SALINE FLUSH - 2ML/IV| ZOMETA - 4MG/MONTHLY| LEXAPRO - 20MG/DAY